Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial
| Autor: | O'Donnell, Elizabeth *, Mo, Clifton, Yee, Andrew J, Nadeem, Omar, Laubach, Jacob, Rosenblatt, Jacalyn, Munshi, Nikhil, Midha, Shonali, Cirstea, Diana, Chrysafi, Pavlina, Horick, Nora, Richardson, Paul G, Raje, Noopur |
|---|---|
| Zdroj: | In The Lancet Haematology June 2024 11(6):e415-e424 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|